Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), bought 46,000 shares at $1.47 ($66K) on 2020-06-09, disclosed to the SEC on 2020-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.41 | 21,000 | $30K | 44.6% |
| 2 | $1.47 | 25,000 | $37K | 55.4% |
| Total | $1.44 avg | 46,000 | $66K | 100% |
| Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |
| TXMD | BUY | 2019-08-12 | $310K | — | Filing → |